Switzerland – Healthcare, Regulatory and Reimbursement Landscape

GlobalData, the industry analysis specialist, has released its latest report, “Switzerland – Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Switzerland. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Swiss pharmaceutical industry is one of the major industries of the country. In 2020, it amounted to about 27.7% of Switzerland’s total exports, making it the country’s largest exporting industry. In terms of Swiss Francs, the country’s pharmaceutical market increased from CHF5.93B in 2013 to CHF6.84B in 2020. It is estimated to increase at a Compound Annual Growth Rate (CAGR) of 1.9% to CHF7.51B in 2025. In the terms of US dollars, the Swiss pharmaceutical market increased from $6.40B in 2013 to $7.28B in 2020, which is estimated to increase at a CAGR of 1.3% to $7.75B in 2025. High expenditure on pharmaceutical R&D and the presence of major pharmaceutical companies have propelled the growth of the pharmaceutical industry. The medical devices market in Switzerland was valued at $2.27B in 2015, which increased to $2.88B in 2020 at a CAGR of 5%. The market is expected to grow at a CAGR of 3% from $3.18B in 2021 to $3.61B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Switzerland, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Pfizer, Novartis, Bayer, and Octapharma.

Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Medtronic, Zimmer Biomet, and Smith-Nephew.

An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in Switzerland healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Switzerland healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Switzerland healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1.Table of Contents

1.1List of Figures

1.2List of Tables

2.Executive Summary

2.1Executive Summary

2.2Key Highlights – Facts about Switzerland Healthcare Market

2.3Key Highlights: Healthcare Startups in Switzerland

2.4Key Events: Switzerland Pharmaceutical News, 2015-2021

2.5Key Events: Switzerland Pharmaceutical Market

2.6Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020

2.7Key Events: Mergers and Acquisitions

2.8Country Profile, Switzerland, 2020

3.Overview of Pharmaceutical Market

3.1Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Key Areas for Building a Strong Pharma hub in Switzerland, Vision: 2030

3.3Pharmaceutical Market – Exports

3.4Pharmaceutical Market – Imports

3.5Pharmaceutical Market – Supply Channels, Switzerland

3.6 Pharmaceutical Market – Illegal Import of Medicines, Switzerland

3.7 Pharmaceutical Market – Market Segments

3.8Major Therapeutic Areas, Switzerland

3.9COVID-19 Epidemiology, Switzerland

3.10COVID-19 Impact and Developments, Switzerland

3.11COVID-19 Clinical Trials Landscape, Switzerland

3.12 Pharmaceutical Market – Major Players

4.Overview of Medical Devices Market

4.1Medical Device Market – Overview

4.2Medical Devices Market – Major Players

5.Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1Drivers

5.2Barriers

6.Deal Analysis

6.1Deal Analysis: Pharmaceutical Market, Switzerland, 2019-2021

6.2 Deal Analysis: Medical Device Market, Switzerland, 2019-2021

7.HealthTech Landscape

7.1HealthTech Landscape, Switzerland

7.2 Adoption of Technology in Healthcare, Switzerland

7.3HealthTech Deals Landscape, Switzerland

7.4 Key HealthTech Deals, Switzerland

7.5 Digital Health Regulations, Switzerland

7.6 HealthTech Landscape: Benefits and Risks, Switzerland

8.Market Access

8.1Overview of Healthcare System, Switzerland

8.2 Drug Reimbursement Process, Switzerland

8.3 Overview of Insurance Providers, Switzerland

8.4 Out-of-Pocket Co-Payments and Safety Nets, Switzerland

8.5Out-of-Pocket Spending and Pharmaceutical Price Index, Switzerland

8.6 Pricing Policies, Switzerland

8.7 Regulatory Landscape, Switzerland

8.7.1 Overview of Regulatory Agencies, Switzerland

8.7.2 Marketing Authorization for Pharmaceutical Products, Switzerland

8.7.3 Marketing Authorization for Generic Medicines, Switzerland

8.7.4 Marketing Authorization for Biosimilars, Switzerland

8.7.5 Marketing Authorization for Medical Devices, Switzerland

8.7.6 Export and Import Regulations, Switzerland

8.7.7 Intellectual Property Rights, Patent, Switzerland

8.7.8 Intellectual Property Rights, Trademark, Switzerland

8.7.9 Clinical Trial Regulation Process, Switzerland

8.7.10 Pharmaceutical Clinical Trials Landscape, Switzerland

8.7.11 Medical Devices Clinical Trials Landscape, Switzerland

8.7.12 Pharmacy License Regulations, Switzerland

8.7.13 Online Pharmacy Regulations, Switzerland

8.7.14Pharmaceutical Advertisement Regulations, Switzerland

8.7.15 Labeling and Packaging Regulations, Switzerland

9.Country Healthcare Landscape

9.1Healthcare Policy Highlights, Switzerland

9.2Healthcare Facilities, Switzerland

9.3Healthcare Parameters, Switzerland

9.4Life Expectancy and Immunization Rate, Switzerland

9.5Environmental Health, Switzerland

9.6Healthcare Personnel, Switzerland

9.7Disease Burden, US Switzerland

9.8Healthcare Expenditure, Switzerland

9.9Healthcare Spending Components and Pharmaceutical Spending, Switzerland

11Trade Associations, Conferences, and Trade Fairs, Switzerland

12Opportunities and Challenges

13Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

List of Tables

Table 1: Pharmaceutical Distribution Channels, Switzerland, 2019

Table 2: Confiscated Shipments: Trend Over the Last Three Years, Switzerland, 2018-2020

Table 3: Origin of Illegal Imports by Country/Region, Switzerland, 2019-2020

Table 4: Confiscated Shipments by Product Categories, Switzerland, 2019-2020

Table 5: Approved Biosimilars, Switzerland, 2017-2019

Table 6: Market Share of Medicines by Therapeutic Indicator Areas, Switzerland, 2019

Table 7: COVID-19 Indicators (Number of Cases), Switzerland and Global, January 2020-July 2021

Table 8: COVID-19-Related Travel Restrictions, Switzerland, 2020-2021

Table 9: Available COVID-19-Vaccines, Switzerland, 2020-2021

Table 10: Available COVID-19 IVD products, Switzerland, 2020-2021

Table 11: Medical Devices Market, Switzerland, Major Segments ($M), 2020

Table 12: Hospital Supplies Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 13: General Surgery Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 14: Orthopedic Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 15: In vitro Diagnostic Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 16: Wound care Management Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 17: Licensed Digital Health Technologies, Switzerland, 2014-2017

Table 18: List of Most Expensive and Least Expensive Cantons, Switzerland

Table 19: Typical Patient Copayments and Safety Nets, Switzerland, 2016

Table 20: Fee for Marketing Authorization of Pharmaceutical Products, Switzerland, 2018

Table 21: Patent Application Fee, Switzerland, 2019

Table 22: Trademark Application Fee, Switzerland, 2019

Table 23: Clinical Trial Application Fee, Switzerland, 2019

Table 24: Trade Fairs, Switzerland

List of Figures

Figure 1: Pharmaceutical Market, Switzerland, Revenue ($B and CHF B), 2013-2020

Figure 2: Medical Devices Market, Switzerland, Revenue ($B), 2015-2020

Figure 3: Healthcare Start-Ups in Switzerland, 2020

Figure 4: Country Profile, Switzerland, 2020

Figure 5: Pharmaceutical Market, Switzerland, Revenue ($B), 2011-2020

Figure 6: Pharmaceutical Market, Switzerland, Revenue Forecast ($B), 2021-2025

Figure 7: Key Areas for Building a Strong Pharma Hub, Switzerland, Vision: 2030

Figure 8: Pharmaceutical Exports ($B), Switzerland, 2011-2020

Figure 9: Top Export Partners, Switzerland, 2020

Figure 10: Pharmaceutical Imports ($B), Switzerland, 2011-2020

Figure 11: Top Import Partners, Switzerland, 2020

Figure 12: Pharmaceutical Supply Channel, Switzerland, 2020

Figure 13: Reasons for Gaps in Medicine Supply, Switzerland, 2020

Figure 14: Generic Drugs Usage (% Share by Volume), Switzerland, 2010-2020

Figure 15: Generic Drugs Usage (% Share by Value), Switzerland, 2010-2020

Figure 16: Self-Medication Market, Switzerland, Revenue ($M), 2011-2019

Figure 17: Self-Medication Market by Drug Category, Revenue ($M), Switzerland, 2019

Figure 18: Major Therapeutic Product Categories by Number of Drugs Authorized, Switzerland, 2019

Figure 19: Major Therapeutic Areas by Pharmaceutical Sales ($M), Switzerland, 2018-2020

Figure 20: Market Share of Medicines by Therapeutic Indicator Areas, Switzerland, 2019

Figure 21: COVID-19 (Number of Cases), Switzerland, 2020-2021

Figure 22: COVID-19 (Number of Deaths), Switzerland, 2020-2021

Figure 23: COVID-19 Fiscal Stimulus Timeline, Switzerland, 2020-2021

Figure 24: COVID-19 Vaccine Administration, Number of Vaccines Administered, Switzerland, 2021

Figure 25: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Switzerland, 2020-2021

Figure 26: Top COVID-19 IVD Products by Device Class (Number of Available Marketed Products), Switzerland, 2020-2021

Figure 27: COVID-19 Clinical Trials Sponsors by Count, Switzerland, 2020-2021

Figure 28: COVID-19 Clinical Trials Count by Phase, Switzerland, 2020-2021

Figure 29: COVID-19 Clinical Trials Count by Trial Status, Switzerland, 2020-2021

Figure 30: Medical Devices Market, Switzerland, Revenue ($B), 2015-2020

Figure 31: Medical Devices Market, Switzerland, Revenue Forecast ($B), 2021-2025

Figure 32: Medical Devices Market, Switzerland, Major Segments (%), 2020

Figure 33: Hospital Supplies Market, Switzerland, Revenue ($M), 2015-2022

Figure 34: Hospital Supplies Market, Switzerland, Market Share of Major Players (%), 2020

Figure 35: General Surgery Devices Market, Switzerland, Revenue ($M), 2015-2022

Figure 36: General Surgery Devices Market, Switzerland, Market Share of Major Players (%), 2020

Figure 37: Orthopedic Devices Market, Switzerland, Revenue ($M), 2015-2022

Figure 38: Orthopedic Devices Market, Switzerland, Market Share of Major Players (%), 2020

Figure 39: In vitro Diagnostic Devices Market, Switzerland, Revenue ($M), 2015-2022

Figure 40: In vitro Diagnostic Devices Market, Switzerland, Market Share of Major Players (%), 2020

Figure 41: Wound care Management Devices Market, Switzerland, Revenue ($M), 2015-2022

Figure 42: Wound care Management Devices Market, Switzerland, Market Share of Major Players (%), 2020

Figure 43: Diagnostic Market, Switzerland, Revenue ($M), 2015-2020

Figure 44: Diagnostic Market, Switzerland, Revenue Forecast ($M), 2021-2025

Figure 45: Medical Devices Market, Switzerland, Revenue ($B) of Major Companies, 2020

Figure 46: Deal Value and Deal Count, Pharmaceutical Market, Switzerland, 2019-2021

Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Switzerland, 2019-2021

Figure 48: Deal Value and Deal Count, Subtypes, Pharmaceutical Market, Switzerland, 2019-2021

Figure 49: Top Therapy Areas by Deal Value, Pharmaceutical Market, Switzerland, 2019-2021

Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, Switzerland, 2019-2021

Figure 51: Mergers and Acquisitions by Quarter, Pharmaceutical Market, Switzerland, 2019-2021 (by Value and by Number)

Figure 52: Venture Financing by Quarter, Pharmaceutical Market, Switzerland, 2019-2021 (by Value and by Number)

Figure 53: Deal Value and Deal Count, Medical Devices Market, Switzerland, 2019-2021

Figure 54: Deal Value and Deal Count, Subtypes, Medical Devices Market, Switzerland, 2019-2021

Figure 55: Deal Value and Deal Count, Quarterly, Medical Devices Market, Switzerland, 2019-2021

Figure 56: Top Equipment Sectors by Deal Value, Medical Devices Market, Switzerland, 2019-2021

Figure 57: Top Equipment Sectors by Deal Count, Medical Devices Market, Switzerland, 2019-2021

Figure 58: Mergers and Acquisitions by Quarter, Medical Devices Market, Switzerland, 2019-2021 (by Value and by Number)

Figure 59: Venture Financing by Quarter, Medical Devices Market, Switzerland, 2019-2021 (by Value and by Number)

Figure 60: Swiss Digital Health Association Ecosystem, Switzerland, 2020

Figure 61: Industrial Technology Facilities, Switzerland, 2020

Figure 62: Swiss Digital Health Start-Up Map, Switzerland, 2021

Figure 63: Deal Value ($M), HealthTech, Switzerland, 2019-2021

Figure 64: Deal Count (Number of Deals), HealthTech, Switzerland, 2019-2021

Figure 65: Key Health Sector Organizations, Switzerland

Figure 66: Overview of Health System, Switzerland, 2020

Figure 67: Reimbursement Process, Switzerland, 2015

Figure 68: Out-of-Pocket Spending ($ per Capita), Switzerland, 2011-2019

Figure 69: Change in Pharmaceutical Price Index (2015 = 100), Switzerland, 2011-2020

Figure 70: Authorized Medicinal Products by Indications, Swissmedic, Switzerland, 2020

Figure 71: Organization Structure, Swissmedic, Switzerland, 2021

Figure 72: Marketing Authorization of Pharmaceutical Products, Swissmedic, Switzerland, 2021

Figure 73: Conformity Assessment of Class I Medical Devices, EU, 2019

Figure 74: Conformity Assessment of Class IIa Medical Devices, EU, 2019

Figure 75: Conformity Assessment of Class IIb Medical Devices, EU, 2019

Figure 76: Conformity Assessment of Class III Medical Devices, EU, 2019

Figure 77: Patent Approval Process, Switzerland, 2019

Figure 78: Trademark Registration Process, Switzerland, 2019

Figure 79: Clinical Trial Approval Process, Switzerland, 2018

Figure 80: Pharmaceutical Clinical Trials Count by Trial Status, Switzerland, 2020-2021

Figure 81: Pharmaceutical Clinical Trials Count by Indication, Switzerland, 2020-2021

Figure 82: Pharmaceutical Clinical Trials Count by Phase, Switzerland, 2020-2021

Figure 83: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Switzerland, 2020-2021

Figure 84: Medical Devices Clinical Trials Count by Trial Status, Switzerland, 2020-2021

Figure 85: Medical Devices Clinical Trials Count by Device Category, Switzerland, 2020-2021

Figure 86: Medical Devices Clinical Trials Count by Indication, Switzerland, 2020-2021

Figure 87: Top Five Medical Devices Clinical Trials Sponsors by Count, Switzerland, 2020-2021

Figure 88: Number of Hospitals, Switzerland, 2012-2020

Figure 89: Number of Diagnostic Equipment, Switzerland, 2015-2020

Figure 90: Number of Acute Care Beds (per 1,000 Population), Switzerland, 2013-2020

Figure 91: Number of Hospital Beds (per 1,000 Population), Switzerland, 2013-2020

Figure 92: Number of Psychiatric Care Beds (per 1,000 Population), Switzerland, 2013-2020

Figure 93: Immunization Rate (% of Children Ages 12-23 Months), Switzerland, 2013-2019

Figure 94: Life Expectancy at Birth (Years), Switzerland, 2013-2019

Figure 95: CO2 Emissions (Million Tons), Switzerland, 2012-2020

Figure 96: PM2.5 (µg per m3), Switzerland, 2012-2020

Figure 97: Physicians (per 1,000 Population), Switzerland, 2012-2020

Figure 98: Pharmacists (per 1,000 Population), Switzerland, 2012-2020

Figure 99: Dentists (per 1,000 Population), Switzerland, 2012-2020

Figure 100: Nurses (per 1,000 Population), Switzerland, 2012-2020

Figure 101: Major Causes of Mortality (per 100,000 population), Switzerland, 2019

Figure 102: Major Causes of Male Mortality (per 100,000 population), Switzerland 2019

Figure 103: Major Causes of Female Mortality (per 100,000 population), Switzerland, 2019

Figure 104: Disability-Adjusted Life Years by Major Disease (per 100,000 population), Switzerland, 2019

Figure 105: Healthcare Expenditure as Percentage of GDP (%), Switzerland, 2012-2019

Figure 106: Health Expenditure Share (% of Total Health Spending), Switzerland, 2012-2019

Figure 107: Pharmaceutical Spending ($ per Capita), Switzerland, 2010-2019

Figure 108: Healthcare Expenditure Components by Function (% of Total Health Expenditure), Switzerland, 2019

Figure 109: Opportunities and Challenges

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports